T0	Outcomes 331 379	the pharmacokinetic interaction and tolerability
T1	Outcomes 792 827	interval of the AUC0-48 h geometric
T2	Outcomes 1028 1041	(0.50, 2.00).
T3	Outcomes 1042 1078	4. Exposures to simvastatin acid and
T4	Outcomes 1293 1313	these TCMs were well